B. Galve-de Rochemonteix

Suppression of metalloproteinase biosynthesis in human alveolar macrophages by interleukin-4.

J. Dayer, C. Baumberger, H. Welgus, 1992, The Journal of clinical investigation.

Interaction of anti-phospholipid antibodies with late endosomes of human endothelial cells.

M. Lindsay, R. Parton, E. Kruithof, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Tumor necrosis factor soluble receptor 75: the principal receptor form released by human alveolar macrophages and monocytes in the presence of interferon gamma.

J. Dayer, L. Nicod, B. Galve-de Rochemonteix, 1996, American journal of respiratory cell and molecular biology.

Regulation of interleukin-1ra, interleukin-1 alpha, and interleukin-1 beta production by human alveolar macrophages with phorbol myristate acetate, lipopolysaccharide, and interleukin-4.

J. Dayer, C. Baumberger, L. Nicod, 1993, American journal of respiratory cell and molecular biology.

Characterization of a specific 20- to 25-kD interleukin-1 inhibitor from cultured human lung macrophages.

J. Dayer, L. Nicod, A. Junod, 1990, American journal of respiratory cell and molecular biology.

Dissociation between allogeneic T cell stimulation and interleukin-1 or tumor necrosis factor production by human lung dendritic cells.

J. Dayer, L. Nicod, B. Galve-de Rochemonteix, 1990, American journal of respiratory cell and molecular biology.

NFκB is an Essential Intermediate in the Activation of Endothelial Cells by Anti-β2-Glycoprotein 1 Antibodies

E. Kruithof, P. Moerloose, P. de Moerloose, 2002, Thrombosis and Haemostasis.

NFkappaB is an essential intermediate in the activation of endothelial cells by anti-beta(2)-glycoprotein 1 antibodies.

E. Kruithof, P. de Moerloose, G. Reber, 2002, Thrombosis and haemostasis.